Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Probst

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Clinical Nuclear Medicine|January 11, 2023
Port-Site Metastasis Identified on Prostate-Specific Membrane Antigen-Targeted 18 F-DCFPyL PET/CT After Robot-Assisted Laparoscopic Radical ProstatectomyHanan Zahed, Jerome Laufer, Martin LeBlanc, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Inferior parietal transcranial direct current stimulation with training improves cognition in anomic Alzheimer's disease and frontotemporal dementiaCarlos Roncero, Heike Kniefel, Erik Service, et al.
Plos One|August 19, 2020
The semantic storage loss score: An Algorithm for measuring an individual's level of semantic storage loss due to temporal lobe damage in neurodegenerative diseaseCarlos Roncero, Jim Nikelski, Stephan Probst, et al.
Frontiers in Oncology|January 9, 2019
Predicting Gleason Score of Prostate Cancer Patients Using Radiomic AnalysisAhmad Chaddad, Tamim Niazi, Stephan Probst, et al.
Clinical Nuclear Medicine|June 20, 2020
Ureteral Metastasis From Prostate Cancer: A PSMA PET PitfallGuillaume Chaussé, Brian Skinnider, Juanita Crook, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2018
<sup>18</sup>F-fluorocholine positron emission tomography-computed tomography (<sup>18</sup>F-FCH PET/CT) for staging of high-risk prostate cancer patientsSimon Gauvin, Alexis Rompré-Brodeur, Guillaume Chaussé, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 27, 2017
Initial single-centre Canadian experience with 18F-fluoromethylcholine positron emission tomography-computed tomography (18F-FCH PET/CT) for biochemical recurrence in prostate cancer patients initially treated with curative intentSimon Gauvin, Yannick Cerantola, Eléonore Haberer, et al.
Frontiers in Neuroscience|December 12, 2019
Maximizing the Treatment Benefit of tDCS in Neurodegenerative AnomiaCarlos Roncero, Erik Service, Marco De Caro, et al.
Case Reports in Oncology|September 5, 2017
Erdheim-Chester Disease: The Importance of Information IntegrationAnna Nikonova, Khashayar Esfahani, Guillaume Chausse, et al.
Nuclear Medicine Communications|December 16, 2022
Comparing digital to analog prostate-specific membrane antigen-targeted piflufolastat 18 F PET/CT in prostate cancer patients in early biochemical failurePeter George Maliha, Benoit Nolet, Anwar Ebrahim, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Clinical Nuclear Medicine|January 11, 2023
Port-Site Metastasis Identified on Prostate-Specific Membrane Antigen-Targeted 18 F-DCFPyL PET/CT After Robot-Assisted Laparoscopic Radical ProstatectomyHanan Zahed, Jerome Laufer, Martin LeBlanc, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Inferior parietal transcranial direct current stimulation with training improves cognition in anomic Alzheimer's disease and frontotemporal dementiaCarlos Roncero, Heike Kniefel, Erik Service, et al.
Plos One|August 19, 2020
The semantic storage loss score: An Algorithm for measuring an individual's level of semantic storage loss due to temporal lobe damage in neurodegenerative diseaseCarlos Roncero, Jim Nikelski, Stephan Probst, et al.
Frontiers in Oncology|January 9, 2019
Predicting Gleason Score of Prostate Cancer Patients Using Radiomic AnalysisAhmad Chaddad, Tamim Niazi, Stephan Probst, et al.
Clinical Nuclear Medicine|June 20, 2020
Ureteral Metastasis From Prostate Cancer: A PSMA PET PitfallGuillaume Chaussé, Brian Skinnider, Juanita Crook, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2018
<sup>18</sup>F-fluorocholine positron emission tomography-computed tomography (<sup>18</sup>F-FCH PET/CT) for staging of high-risk prostate cancer patientsSimon Gauvin, Alexis Rompré-Brodeur, Guillaume Chaussé, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 27, 2017
Initial single-centre Canadian experience with 18F-fluoromethylcholine positron emission tomography-computed tomography (18F-FCH PET/CT) for biochemical recurrence in prostate cancer patients initially treated with curative intentSimon Gauvin, Yannick Cerantola, Eléonore Haberer, et al.
Frontiers in Neuroscience|December 12, 2019
Maximizing the Treatment Benefit of tDCS in Neurodegenerative AnomiaCarlos Roncero, Erik Service, Marco De Caro, et al.
Case Reports in Oncology|September 5, 2017
Erdheim-Chester Disease: The Importance of Information IntegrationAnna Nikonova, Khashayar Esfahani, Guillaume Chausse, et al.
Nuclear Medicine Communications|December 16, 2022
Comparing digital to analog prostate-specific membrane antigen-targeted piflufolastat 18 F PET/CT in prostate cancer patients in early biochemical failurePeter George Maliha, Benoit Nolet, Anwar Ebrahim, et al.
Pageof 7